Funded by the NIH HEAL Initiative®
This study will examine whether 1) in hospitals with addiction medicine consultation services, hospital-initiated extended release buprenorphine (XR-BUP), compared to other OUD medications, results in increased OUD treatment engagement following hospital discharge; and 2) training hospitals without such consultation services on best practices for initiating OUD medication using consultation service hubs improves medication uptake in hospitals and following discharge.
NCT04345718
Gavin Bart, M.D., Ph.D., FACP, FASAM
Director, Addiction Medicine
Minneapolis Medical Research Foundation
Hennepin County Medical Center
701 Park Avenue G5, Minneapolis, MN, 55415, US
Richard Saitz, MD, MPH, FACP, DFASAM
Chair, Department of Community Health Sciences
Boston University School of Public Health
801 Massachusetts Ave., 4th Floor, Boston, MA, 02118, US
CTN-0098 active